Moulid Hidayat

Oct4 plays a crucial role in the maintenance of gefitinib-resistant lung cancer stem cells

Isao Kobayashi, Fumiyuki Takahashi, Fariz Nurwidya et al. · Biochemical and Biophysical Research Communications · 2016 · 69 citations

Life Sciences, Molecular Biology, Oncology +14

Cancer‐associated fibroblast migration in non‐small cell lung cancers is modulated by increased integrin α11 expression

Moe Iwai, Miniwan Tulafu, Shinsaku Togo et al. · Molecular Oncology · 2021 · 52 citations · Full text

Medicine, Cancer Biology, Oncology +17

Activation of insulin‐like growth factor‐1 receptor confers acquired resistance to osimertinib in non‐small cell lung cancer with <i>EGFR</i> T790M mutation

Daisuke Hayakawa, Fumiyuki Takahashi, Yoichiro Mitsuishi et al. · Thoracic Cancer · 2019 · 50 citations · Full text

Medicine, Oncology, Pharmacology +17

Nintedanib inhibits epithelial-mesenchymal transition in A549 alveolar epithelial cells through regulation of the TGF-β/Smad pathway

Hiroaki Ihara, Yoichiro Mitsuishi, Motoyasu Kato et al. · Respiratory Investigation · 2020 · 46 citations

Life Sciences, Cell Biology, Molecular Biology +12

Treatment with insulin-like growth factor 1 receptor inhibitor reverses hypoxia-induced epithelial–mesenchymal transition in non-small cell lung cancer

Fariz Nurwidya, Fumiyuki Takahashi, Isao Kobayashi et al. · Biochemical and Biophysical Research Communications · 2014 · 42 citations · Full text

Medicine, Oncology, Pharmacology +17